Immune checkpoint molecules, such as PD-1/PD-L1, are reported to be closely associated with suppression of antitumor immunity [5, 6], and their inhibitors have been used to treat various cancers including bladder cancer [7–12]. Here, CD274 is linked to urinary bladder cancer.